Share of Clicks for top 10 US Pharma & Biotech Oncology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| themmrf.org | 6.82 |
| kisqali-hcp.com | 5.69 |
| keytruda.com | 4.57 |
| mayoclinic.org | 4.32 |
| kisqali.com | 3.69 |
| lilly.com | 3.57 |
| mdanderson.org | 3.37 |
| ibrance.com | 3.16 |
| breyanzi.com | 2.92 |
| opdivo.com | 2.01 |
| others | 59.88 |
- themmrf.org - 6.82%
- kisqali-hcp.com - 5.69%
- keytruda.com - 4.57%
- mayoclinic.org - 4.32%
- kisqali.com - 3.69%
- lilly.com - 3.57%
- mdanderson.org - 3.37%
- ibrance.com - 3.16%
- breyanzi.com - 2.92%
- opdivo.com - 2.01%
- others - 59.88%
Copyright © Adthena. All rights reserved.
In the oncology PPC landscape, ‘others’ dominate with 59.88% click share, overshadowing ‘themmrf.org’ at 6.82% and ‘kisqali-hcp.com’ at 5.69%.
Share of Spend for the top 10 US Pharma & Biotech Oncology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | kisqali.com | kisqali-hcp.com | ibrance.com | keytruda.com | themmrf.org | lilly.com | opdivo.com | breyanzi.com | mdanderson.org | mayoclinic.org |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/07/01 | 8.45% | 8.99% | 3.64% | 3.98% | 3.33% | 4.04% | 2.68% | 2.11% | 2.58% | 2.78% |
| 2026/07/02 | 7.86% | 7.83% | 3.18% | 4.29% | 5.49% | 3.76% | 2.06% | 2% | 3.48% | 3.07% |
| 2026/07/03 | 7.75% | 7.03% | 3.77% | 4.83% | 4.88% | 3.48% | 2.1% | 2.53% | 3.65% | 2.89% |
| 2026/07/04 | 6.69% | 6.79% | 4.01% | 4.91% | 2.95% | 4.26% | 1.84% | 2.3% | 5.55% | 3.47% |
| 2026/07/05 | 6.1% | 6.32% | 4.02% | 4.05% | 3.24% | 4.29% | 2.35% | 2.57% | 5.48% | 2.68% |
| 2026/07/06 | 6.78% | 6% | 3.82% | 3.92% | 3.47% | 3.79% | 2.75% | 2.24% | 2.61% | 3.44% |
| 2026/07/07 | 7.5% | 6.54% | 3.93% | 3.28% | 5.25% | 4.11% | 2.44% | 2.5% | 1.61% | 1.52% |
| 2026/07/08 | 8.59% | 7.23% | 3.96% | 3.52% | 4.86% | 3.81% | 2.18% | 2.29% | 1.79% | 2.65% |
| 2026/07/09 | 8.73% | 7.37% | 4.38% | 4.2% | 7.05% | 4.56% | 2.11% | 2.47% | 2.3% | 2.81% |
| 2026/07/10 | 9.09% | 7.87% | 3.92% | 3.77% | 7.7% | 4.27% | 2.35% | 2.21% | 0.96% | 2.88% |
| 2026/07/11 | 10.19% | 8.38% | 3.89% | 4.64% | 2.7% | 3.75% | 2.11% | 2.24% | 3.94% | 4.16% |
| 2026/07/12 | 8.92% | 7.09% | 3.36% | 4.11% | 4.04% | 3.98% | 2.38% | 2.54% | 3.86% | 2.98% |
| 2026/07/13 | 8.58% | 7.03% | 3.5% | 3.74% | 8.77% | 3.71% | 2.38% | 2.53% | 1.82% | 3.36% |
| 2026/07/14 | 10.13% | 7.86% | 3.86% | 3.99% | 6.63% | 3.68% | 2.67% | 2.41% | 2.85% | 2.52% |
| 2026/07/15 | 9.97% | 7.67% | 3.77% | 3.89% | 8.27% | 3.3% | 2.46% | 2.93% | 2.21% | 1.28% |
| 2026/07/16 | 8% | 8.08% | 4.72% | 3.79% | 3.5% | 4.05% | 2.66% | 3.17% | 2.61% | 1.93% |
| 2026/07/17 | 8.51% | 7.6% | 4.39% | 4.48% | 9.58% | 3.89% | 2.44% | 1.94% | 2.63% | 1.47% |
| 2026/07/18 | 7.22% | 7.89% | 4.38% | 4.35% | 7.79% | 3.74% | 2.57% | 2.3% | 4.4% | 3.91% |
| 2026/07/19 | 8.66% | 8.03% | 4.06% | 4.13% | 5.66% | 3.34% | 2.48% | 3.35% | 3.72% | 2% |
| 2026/07/20 | 14.67% | 8.65% | 4% | 3.95% | 4.74% | 3.35% | 2.28% | 2.44% | 1.11% | 2.02% |
| 2026/07/21 | 10.08% | 7.82% | 3.84% | 3.97% | 6.6% | 3.67% | 2.66% | 2.4% | 2.84% | 2.51% |
| 2026/07/22 | 7.77% | 8% | 3.92% | 4.78% | 5.5% | 4.32% | 1.94% | 2.4% | 2.81% | 4.09% |
| 2026/07/23 | 8.13% | 8.39% | 3.88% | 4.82% | 6.29% | 4.05% | 2.37% | 2.34% | 2.87% | 2.86% |
| 2026/07/24 | 6.85% | 7.54% | 4.13% | 3.54% | 4.19% | 4.02% | 2.75% | 2.97% | 2.85% | 2.7% |
| 2026/07/25 | 7.37% | 7.03% | 3.97% | 4.64% | 7.14% | 4.08% | 2.37% | 2.63% | 3.26% | 2.18% |
| 2026/07/26 | 8.72% | 7.62% | 3.67% | 4.96% | 6.19% | 3.68% | 1.92% | 2.88% | 3.5% | 4.01% |
| 2026/07/27 | 9% | 7.53% | 3.52% | 3.8% | 5.06% | 3.38% | 2.6% | 2.67% | 1.89% | 2.07% |
| 2026/07/28 | 8.57% | 7.76% | 3.53% | 3.88% | 2.41% | 3.74% | 2.03% | 2.61% | 3.1% | 2.9% |
| 2026/07/29 | 10.16% | 8.29% | 3.92% | 4.41% | 3.1% | 4.31% | 2.03% | 2.5% | 2.18% | 1.71% |
| 2026/07/30 | 9.7% | 8.55% | 3.25% | 4.76% | 5.19% | 4.15% | 2.75% | 2.9% | 1.96% | 2.44% |
| 2026/07/31 | 9.79% | 7.48% | 7.44% | 4.77% | 4.62% | 2.82% | 2.75% | 2.72% | 2.62% | 1.92% |
- kisqali.com
- kisqali-hcp.com
- ibrance.com
- keytruda.com
- themmrf.org
- lilly.com
- opdivo.com
- breyanzi.com
- mdanderson.org
- mayoclinic.org
Copyright © Adthena. All rights reserved.
In July 2026, kisqali.com led with a peak spend share of 14.67% on the 20th. Meanwhile, kisqali-hcp.com and ibrance.com showed steady fluctuations. Keytruda.com and themmrf.org experienced notable peaks mid-month. The month concluded with kisqali.com maintaining dominance.
Competitor Count for US Pharma & Biotech Oncology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/07/01 | 415 |
| 2026/07/02 | 422 |
| 2026/07/03 | 420 |
| 2026/07/04 | 418 |
| 2026/07/05 | 422 |
| 2026/07/06 | 424 |
| 2026/07/07 | 420 |
| 2026/07/08 | 410 |
| 2026/07/09 | 410 |
| 2026/07/10 | 409 |
| 2026/07/11 | 401 |
| 2026/07/12 | 404 |
| 2026/07/13 | 414 |
| 2026/07/14 | 409 |
| 2026/07/15 | 406 |
| 2026/07/16 | 401 |
| 2026/07/17 | 396 |
| 2026/07/18 | 402 |
| 2026/07/19 | 393 |
| 2026/07/20 | 387 |
| 2026/07/21 | 409 |
| 2026/07/22 | 410 |
| 2026/07/23 | 420 |
| 2026/07/24 | 420 |
| 2026/07/25 | 433 |
| 2026/07/26 | 427 |
| 2026/07/27 | 434 |
| 2026/07/28 | 432 |
| 2026/07/29 | 430 |
| 2026/07/30 | 424 |
| 2026/07/31 | 418 |
Copyright © Adthena. All rights reserved.
Advertisers fluctuated in July, starting at 415, dipping mid-month, then peaking at 434, ending at 418.
